crofelemer 125 MG Delayed Release Oral Tablet [Mytesi]

Verify with CMS →

crofelemer

RxCUI: 1806878

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
2.9%
Plan Coverage
148
Plans Covering
T4.3
Avg Tier
61.5%
Prior Auth Required

What the CMS Formulary Data Shows for crofelemer 125 MG Delayed Release Oral Tablet [Mytesi]

Per the CMS 2026 Part D formulary file, crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] (RxNorm concept RXCUI 1806878, generic name crofelemer) appears on 13 distinct formulary files spanning 148 Medicare Part D plan offerings - 2.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 5, with a cross-plan average of Tier 4.3.

Real-world access to crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] depends on utilization management as much as tier placement: 61.5% of covering formularies require prior authorization. 0% require step therapy. 23.1% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 379 Part D beneficiaries filled crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] in 2023, with total plan-and-beneficiary spending of $7,449,992 and an average per-beneficiary annual cost of $19,656.97. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] today.

Coverage Details

Formularies covering
13
Plans covering
148
Coverage rate
2.9%
Tier range
Tier 2 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
61.5% of formularies
Step therapy required
0% of formularies
Quantity limits
23.1% of formularies

2023 Medicare Spending

Beneficiaries
379
Total spending
$7,449,992
Avg per beneficiary
$19,656.97

Tier Distribution Across Plans

1 plans
Tier 2, Generic
60 plans
Tier 4, Non-Preferred
39 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering crofelemer 125 MG Delayed Release Oral Tablet [Mytesi]

100 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T2 Yes $0 CA
Freedom VIP Care (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom VIP Savings (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom VIP Savings (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom VIP Rewards (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom VIP Rewards (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Optimum Diamond Rewards (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Diamond Savings (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Diamond Rewards (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Diamond (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Freedom Medi-Medi Partial (HMO D-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Medi-Medi Full (HMO D-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Optimum Emerald Partial (HMO D-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Emerald Full (HMO D-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Freedom Medicare Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Medicare Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom VIP Savings COPD (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom VIP Savings COPD (HMO C-SNP) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Rewards Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Rewards Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Rewards Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Rewards Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Rewards Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Platinum Rewards Plan Rx (HMO) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Máximo (HMO-POS) FREEDOM HEALTH, INC. T4 No $0 FL
Freedom Máximo (HMO-POS) FREEDOM HEALTH, INC. T4 No $0 FL
Optimum Gold Rewards Plan (HMO) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Platinum Plan (HMO) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Gold Plan (HMO) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Gold Rewards Plan (HMO) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Gold Rewards Plan (HMO) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Diamond Rewards COPD (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Diamond Savings COPD (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Gold Plus Plan (HMO) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Optimum Diamond Rewards COPD (HMO C-SNP) OPTIMUM HEALTHCARE, INC. T4 No $0 FL
Medicare BlueEssential (PPO) EXCELLUS HEALTH PLAN, INC. T4 Yes $0 NY
Medicare BlueActive (PPO) EXCELLUS HEALTH PLAN, INC. T4 Yes $0 NY
Medicare BlueVital (PPO) EXCELLUS HEALTH PLAN, INC. T4 Yes $0 NY
Univera SeniorChoice Basic (HMO) EXCELLUS HEALTH PLAN, INC. T4 Yes $0 NY
Univera SeniorChoice Extra (HMO) EXCELLUS HEALTH PLAN, INC. T4 Yes $0 NY
Medicare Blue Choice Core (HMO) EXCELLUS HEALTH PLAN, INC. T4 Yes $0 NY
Univera Medicare Dual (HMO D-SNP) EXCELLUS HEALTH PLAN COMMUNITY CARE LLC T4 Yes $0 NY
Medicare Blue Dual (HMO D-SNP) EXCELLUS HEALTH PLAN COMMUNITY CARE LLC T4 Yes $0 NY
CDPHP $0 Medicare Rx (HMO) CAPITAL DISTRICT PHYSICIANS' HEALTH PLAN, INC. T4 Yes $0 NY
Univera SeniorChoice Core (PPO) EXCELLUS HEALTH PLAN, INC. T4 Yes $33.00 NY

Frequently Asked Questions

Is crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] covered by Medicare Part D?

Yes, crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] is covered by 148 Medicare Part D plans (2.9% of all Part D formularies).

What tier is crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] on Medicare Part D plans?

crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] averages Tier 4.3 across Part D plans, ranging from Tier 2 to Tier 5.

Does crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] require prior authorization?

61.5% of Part D formularies require prior authorization for crofelemer 125 MG Delayed Release Oral Tablet [Mytesi]. Step therapy: 0%. Quantity limits: 23.1%.

How much does Medicare spend on crofelemer 125 MG Delayed Release Oral Tablet [Mytesi]?

In 2023, total Medicare Part D spending on crofelemer 125 MG Delayed Release Oral Tablet [Mytesi] was $7,449,992, covering 379 beneficiaries. The average spend per beneficiary was $19,656.97.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial